Journal
ADMET AND DMPK
Volume 8, Issue 4, Pages 375-390Publisher
IAPC PUBLISHING
DOI: 10.5599/admet.881
Keywords
Nano particle; nano drug delivery; nanomedicines; intestinal perfusion; pharmaceutical development
Categories
Ask authors/readers for more resources
An established pharmaceutical strategy to increase oral drug absorption of low solubility-high permeability drugs is to create nanoparticles of them. Reducing the size of the solid-state particles increases their dissolution and transport rate across the mucus barrier and the aqueous boundary layer. Suspensions of nanoparticles also sometimes behave differently than those of larger particles in the fed state. This review compares the absorption mechanisms of nano- and larger particles in the lumen at different prandial states, with an emphasis on data derived from in vivo models. Four BSC class II drugs-aprepitant, cyclosporine, danazol and fenofibrate-are discussed in detail based on information from preclinical intestinal perfusion models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available